<?xml version="1.0" ?>
<document id="741b4227809cd635e7f0f06cf4f70331a9764b5f">
  <chunk id="741b4227809cd635e7f0f06cf4f70331a9764b5f.c0" text="A computational analysis of SARS cysteine proteinase-octapeptide substrate interaction: implication for structure and active site binding mechanism">
    <entity charOffset="130-137" id="741b4227809cd635e7f0f06cf4f70331a9764b5f.c0.e0" ontology_id="GO_0005488" text="binding" type="gene_function"/>
  </chunk>
  <chunk id="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1" text="Background: SARS coronavirus main proteinase (SARS CoVMpro) is an important enzyme for the replication of Severe Acute Respiratory Syndrome virus. The active site region of SARS CoVMpro is divided into 8 subsites. Understanding the binding mode of SARS CoVMpro with a specific substrate is useful and contributes to structural-based drug design. The purpose of this research is to investigate the binding mode between the SARS CoVMpro and two octapeptides, especially in the region of the S3 subsite, through a molecular docking and molecular dynamics (MD) simulation approach.">
    <entity charOffset="106-112" id="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1.e0" ontology_id="HP_0012828" text="Severe" type="phenotype"/>
    <entity charOffset="113-118" id="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1.e1" ontology_id="HP_0011009" text="Acute" type="phenotype"/>
    <entity charOffset="232-239" id="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1.e2" ontology_id="GO_0005488" text="binding" type="gene_function"/>
    <entity charOffset="397-404" id="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1.e3" ontology_id="GO_0005488" text="binding" type="gene_function"/>
    <pair e1="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1.e0" e2="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1.e2" id="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1.p0" relation="true"/>
    <pair e1="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1.e0" e2="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1.e3" id="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1.p1" relation="true"/>
    <pair e1="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1.e1" e2="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1.e2" id="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1.p2" relation="true"/>
    <pair e1="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1.e1" e2="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1.e3" id="741b4227809cd635e7f0f06cf4f70331a9764b5f.c1.p3" relation="true"/>
  </chunk>
  <chunk id="741b4227809cd635e7f0f06cf4f70331a9764b5f.c2" text="The one turn Î±-helix chain (residues 47-54) of the SARS CoVMpro was directly involved in the induced-fit model of the enzyme-substrate complex. The S3 subsite of the enzyme had a negatively charged region due to the presence of Glu47. During MD simulations, Glu47 of the enzyme was shown to play a key role in electrostatic bonding with the P3Lys of the octapeptide."/>
  <chunk id="741b4227809cd635e7f0f06cf4f70331a9764b5f.c3" text="Conclusion: MD simulations were carried out on the SARS CoVMpro-octapeptide complex. The hypothesis proposed that Glu47 of SARS CoVMpro is an important residue in the S3 subsite and is involved in binding with P3Lys of the octapeptide.">
    <entity charOffset="197-204" id="741b4227809cd635e7f0f06cf4f70331a9764b5f.c3.e0" ontology_id="GO_0005488" text="binding" type="gene_function"/>
  </chunk>
</document>
